These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 10847561)

  • 1. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease.
    Pappolla MA; Chyan YJ; Poeggeler B; Frangione B; Wilson G; Ghiso J; Reiter RJ
    J Neural Transm (Vienna); 2000; 107(2):203-31. PubMed ID: 10847561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism.
    Reiter RJ; Cabrera J; Sainz RM; Mayo JC; Manchester LC; Tan DX
    Ann N Y Acad Sci; 1999; 890():471-85. PubMed ID: 10668453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors.
    Pappolla MA; Simovich MJ; Bryant-Thomas T; Chyan YJ; Poeggeler B; Dubocovich M; Bick R; Perry G; Cruz-Sanchez F; Smith MA
    J Pineal Res; 2002 Apr; 32(3):135-42. PubMed ID: 12074096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model for the pathophysiology of Alzheimer's disease. Aluminium toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment and melatonin.
    van Rensburg SJ; Daniels WM; Potocnik FC; van Zyl JM; Taljaard JJ; Emsley RA
    S Afr Med J; 1997 Sep; 87(9):1111-5. PubMed ID: 9358827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    López-Iglesias B; Pérez C; Morales-García JA; Alonso-Gil S; Pérez-Castillo A; Romero A; López MG; Villarroya M; Conde S; Rodríguez-Franco MI
    J Med Chem; 2014 May; 57(9):3773-85. PubMed ID: 24738476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage.
    Gurer-Orhan H; Karaaslan C; Ozcan S; Firuzi O; Tavakkoli M; Saso L; Suzen S
    Bioorg Med Chem; 2016 Apr; 24(8):1658-64. PubMed ID: 26970662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of melatonin in Alzheimer-like neurodegeneration.
    Wang JZ; Wang ZF
    Acta Pharmacol Sin; 2006 Jan; 27(1):41-9. PubMed ID: 16364209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
    Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
    Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin.
    Pappolla MA; Chyan YJ; Poeggeler B; Bozner P; Ghiso J; LeDoux SP; Wilson GL
    J Pineal Res; 1999 Nov; 27(4):226-9. PubMed ID: 10551770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites.
    Reiter RJ; Tan DX; Jou MJ; Korkmaz A; Manchester LC; Paredes SD
    Neuro Endocrinol Lett; 2008 Aug; 29(4):391-8. PubMed ID: 18766165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oxidant/antioxidant network: role of melatonin.
    Reiter RJ; Tan DX; Cabrera J; D'Arpa D; Sainz RM; Mayo JC; Ramos S
    Biol Signals Recept; 1999; 8(1-2):56-63. PubMed ID: 10085463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.
    Reiter RJ; Tan DX; Allegra M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin: an ancient molecule that makes oxygen metabolically tolerable.
    Manchester LC; Coto-Montes A; Boga JA; Andersen LP; Zhou Z; Galano A; Vriend J; Tan DX; Reiter RJ
    J Pineal Res; 2015 Nov; 59(4):403-19. PubMed ID: 26272235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Melatonin as an antioxidant].
    Skrzydlewska E
    Postepy Hig Med Dosw; 2001; 55(6):871-89. PubMed ID: 11875783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
    Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
    ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of melatonin in experimental models of Alzheimer disease.
    Cheng Y; Feng Z; Zhang QZ; Zhang JT
    Acta Pharmacol Sin; 2006 Feb; 27(2):129-39. PubMed ID: 16412260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease.
    Miranda S; Opazo C; Larrondo LF; Muñoz FJ; Ruiz F; Leighton F; Inestrosa NC
    Prog Neurobiol; 2000 Dec; 62(6):633-48. PubMed ID: 10880853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin prevents free radical formation due to the interaction between beta-amyloid peptides and metal ions [Al(III), Zn(II), Cu(II), Mn(II), Fe(II)].
    Zatta P; Tognon G; Carampin P
    J Pineal Res; 2003 Sep; 35(2):98-103. PubMed ID: 12887652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.